| Bioactivity | Etripamil (MSP-2017) hydrochloride is a short-acting, L-type calcium channel antagonist that can be used in the study of paroxysmal supraventricular tachycardia (PSVT). Etripamil hydrochloride inhibits calcium influx through slow calcium channels, thereby slowing atrioventricular node conduction and prolonging the atrioventricular node refractory period. |
| CAS | 2560549-35-9 |
| Formula | C27H37ClN2O4 |
| Molar Mass | 489.05 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pokorney S D, et al. CO143 Impact of Investigational, at-Home, Self-Administered, Intranasal Etripamil on the Need for Additional Medical Intervention in Patients with Supraventricular Tachycardia[J]. Value in Health, 2023, 26(6): S41. |
Etripamil hydrochloride
CAS: 2560549-35-9 F: C27H37ClN2O4 W: 489.05
Etripamil (MSP-2017) hydrochloride is a short-acting, L-type calcium channel antagonist that can be used in the study of
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.